chr1-211673534-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_002497.4(NEK2):āc.504T>Cā(p.His168His) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.511 in 1,613,692 control chromosomes in the GnomAD database, including 215,163 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.54 ( 22444 hom., cov: 33)
Exomes š: 0.51 ( 192719 hom. )
Consequence
NEK2
NM_002497.4 synonymous
NM_002497.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.573
Genes affected
NEK2 (HGNC:7745): (NIMA related kinase 2) This gene encodes a serine/threonine-protein kinase that is involved in mitotic regulation. This protein is localized to the centrosome, and undetectable during G1 phase, but accumulates progressively throughout the S phase, reaching maximal levels in late G2 phase. Alternatively spliced transcript variants encoding different isoforms with distinct C-termini have been noted for this gene. [provided by RefSeq, Feb 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 1-211673534-A-G is Benign according to our data. Variant chr1-211673534-A-G is described in ClinVar as [Benign]. Clinvar id is 403228.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.573 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.711 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NEK2 | NM_002497.4 | c.504T>C | p.His168His | synonymous_variant | 3/8 | ENST00000366999.9 | NP_002488.1 | |
NEK2 | NM_001204182.2 | c.504T>C | p.His168His | synonymous_variant | 3/8 | NP_001191111.1 | ||
NEK2 | NM_001204183.2 | c.504T>C | p.His168His | synonymous_variant | 3/7 | NP_001191112.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NEK2 | ENST00000366999.9 | c.504T>C | p.His168His | synonymous_variant | 3/8 | 1 | NM_002497.4 | ENSP00000355966.4 | ||
NEK2 | ENST00000540251.5 | c.504T>C | p.His168His | synonymous_variant | 3/8 | 1 | ENSP00000440237.2 | |||
NEK2 | ENST00000366998.4 | c.504T>C | p.His168His | synonymous_variant | 3/7 | 1 | ENSP00000355965.3 |
Frequencies
GnomAD3 genomes AF: 0.538 AC: 81766AN: 151964Hom.: 22412 Cov.: 33
GnomAD3 genomes
AF:
AC:
81766
AN:
151964
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.567 AC: 142349AN: 251222Hom.: 41957 AF XY: 0.563 AC XY: 76411AN XY: 135802
GnomAD3 exomes
AF:
AC:
142349
AN:
251222
Hom.:
AF XY:
AC XY:
76411
AN XY:
135802
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.508 AC: 742295AN: 1461608Hom.: 192719 Cov.: 49 AF XY: 0.511 AC XY: 371273AN XY: 727116
GnomAD4 exome
AF:
AC:
742295
AN:
1461608
Hom.:
Cov.:
49
AF XY:
AC XY:
371273
AN XY:
727116
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.538 AC: 81846AN: 152084Hom.: 22444 Cov.: 33 AF XY: 0.545 AC XY: 40522AN XY: 74332
GnomAD4 genome
AF:
AC:
81846
AN:
152084
Hom.:
Cov.:
33
AF XY:
AC XY:
40522
AN XY:
74332
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2309
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 28, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency - |
Retinitis pigmentosa 67 Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Sep 05, 2021 | - - |
Retinal dystrophy Benign:1
Benign, criteria provided, single submitter | research | Dept Of Ophthalmology, Nagoya University | Oct 01, 2023 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at